The Recall Desk
HighFDA (Drugs)·D-1409-2014·Announced 2014-07-02

Pfizer Recalls Pristiq 50 mg Tablets Due to Foreign 100 mg Tablet

Pfizer is recalling Pristiq 50 mg extended-release tablets because a 100 mg tablet was found in a bottle labeled for 50 mg.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (wrong dosage of prescription medication) where injury has not yet been reported, fitting the High severity criteria.

Plain-English summary

Pfizer is recalling Pristiq (desvenlafaxine) 50 mg extended-release tablets. The recall was initiated because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.

The affected product is Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, distributed by Wyeth Pharmaceuticals, Inc. The recall involves 220,761 bottles distributed nationwide. Specific lot codes include H74477, H74478, H74479, and H79766, with expiration dates of 03/16 and 05/16.

Consumers should check their medication for the affected lot codes and expiration dates. If the medication matches the recalled description, they should stop using it and contact their healthcare provider or pharmacist for guidance.

The recalled product

Product
PRISTIQ (DESVENLAFAXINE SUCCINATE)
Brand
PRISTIQ
Affected units
220,761

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • H74477
  • H74478
  • Exp. 03/16
  • H74479
  • H79766 Exp. 05/16

UPCs (3)

  • 0300081210306
  • 0300081222309
  • 0300081211303

Distribution

Distributed nationwide across the United States.

Same manufacturer · Pfizer Us Pharmaceutical Group

See all →